Finance

Lists
Why is 301075 down 5,09%?
Dive Deeper
301075:SHE
Tibet Duo Rui Pharmaceutical Co Ltd
CN¥55,51
-5,09%
(-2,98) 1D
13 Okt., 10:46:43 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301075...
Open
CN¥58,49
High
CN¥58,49
Low
CN¥55,00
Mkt. cap
4,80 mjd
Avg. vol.
1,20 m
Volume
483,40 k
52-wk high
CN¥98,29
52-wk low
CN¥40,91
EPS
-CN¥0,62
Shares outstanding
80,00 m
No. of employees
461
Open
CN¥58,49
High
CN¥58,49
Low
CN¥55,00
Mkt. cap
4,80 mjd
Avg. vol.
1,20 m
Volume
483,40 k
52-wk high
CN¥98,29
52-wk low
CN¥40,91
EPS
-CN¥0,62
Shares outstanding
80,00 m
No. of employees
461
News stories
From web sources and news partners
About Tibet Duo Rui Pharmaceutical Co Ltd
CEO-
Employees461
Founded2005
Headquarters-
SectorPharmaceutical industry
Websiteduoruiyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
30,43 m
17,18 m
32,43 m
63,22 m
Cost of goods sold
32,04 m
16,74 m
29,99 m
55,51 m
Cost of revenue
32,04 m
16,74 m
29,99 m
55,51 m
Research and development expenses
20,93 m
-8,19 m
4,94 m
8,48 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,76 m
22,19 m
15,08 m
15,52 m
Operating expense
47,89 m
12,94 m
17,03 m
25,10 m
Total operating expenses
79,93 m
29,68 m
47,01 m
80,61 m
Operating income
-49,50 m
-12,51 m
-14,58 m
-17,38 m
Other non operating income
-869,13 k
-2,55 m
-34,06 k
-195,80 k
EBT including unusual items
-52,43 m
-20,21 m
-18,95 m
25,20 m
EBT excluding unusual items
-54,28 m
-19,39 m
-17,93 m
19,35 m
Income tax expense
413,36 k
-503,13 k
62,27 k
2,94 m
Effective tax rate
-0,79%
2,49%
-0,33%
11,69%
Other operating expenses
1,76 m
88,27 k
-1,24 m
2,31 m
Net income
-37,22 m
-22,44 m
-13,97 m
25,50 m
Net profit margin
-122,35%
-130,64%
-43,07%
40,33%
Earnings per share
-
-
-
-
Interest and investment income
-
455,41 k
18,98 k
40,22 m
Interest expense
-3,91 m
-4,79 m
-3,34 m
-3,27 m
Net interest expenses
-3,91 m
-4,33 m
-3,32 m
36,95 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-42,82 m
-296,34 k
-2,37 m
-4,81 m
Gain or loss from assets sale
-9,56 k
105,45 k
-
-242,76 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme